About RDI

RDI is your full-service, integrated partner for IVD research

We bring together a high-complexity CLIA lab, a technology-enabled CRO, and a clinical and laboratory site network to accelerate your product’s development.  

Our Mission

RDI is a contract research organization that understands the complexity of IVD development. We connect IVD manufacturers dissatisfied with slow patient enrollment for their trials with the patients they desperately need by recruiting, educating, and training physicians & labs to take part in in vitro diagnostic studies.  

Unlike many other CROs, RDI can source, test, and submit to the FDA, simplifying the clinical trial process while serving as a credible, unbiased, and independent source for the FDA submission.  

RDI is the leader in diagnostic trials. Let us be your first call to accelerate your IVD product to market.  

Our Story

2008

RDI Founded by Scientist

RDI was founded by an ex-Siemens assay validation scientist, foreseeing a need for an interdependent IVD specialist that could accelerate trials with a physician and lab network trained in research.  

2017

RDI Brings in Expert Leadership 

RDI was acquired by an investor group led by Conall Arora to further professionalize operations and expand its physician network through a custom developed and paperless trial management system.    

2022

RDI Invests in Physician Network

RDI hires a dedicated site network team, armed with insurance claims data to better target any physician in the country.   

2023

RDI Adds CLIA Lab and Upgrades Scientific Leadership

RDI received CLIA certification after hiring Dr. Michael Samoszuk as its new principal investigator and medical lab director and Dr. Elisa Romeo to serve as lead principal investigator for prospective collections.  

RDI was founded by an ex-Siemens assay validation scientist, foreseeing a need for an interdependent IVD specialist that could accelerate trials with a physician and lab network trained in research.  

RDI was acquired by an investor group led by Conall Arora to further professionalize operations and expand its physician network through a custom developed and paperless trial management system.  

RDI hires a dedicated site network team, armed with insurance claims data to better target any physician in the country.  

RDI Adds CLIA Lab and Upgrades Scientific Leadership 

RDI received CLIA certification after hiring Dr. Michael Samoszuk as its new principal investigator and medical lab director and Dr. Elisa Romeo to serve as lead principal investigator for prospective collections.  

Our Team

A Partnership-Focused Approach 

We have fostered strong relationships with our partners, including lab suppliers and IRBs. By taking a collaborative approach, we also build long-lasting and productive partnerships with our clients, many of which are top 5-10 IVD companies.  

Upcoming Events

Stay tuned for upcoming events!

Ready to accelerate your IVD trial?

RDI stands out as one of the only collaborative, full-service partners dedicated to IVD research. Our focus and expertise position us to pave a clear path to FDA clearance for your product. Backed by vast resources and a commitment to transparent partnership, we are the trusted choice for IVD development.

Let's Talk